adverse event reporting in pigs
play

Adverse event reporting in pigs Ken Steen Pedersen www.oevet.dk - PowerPoint PPT Presentation

Mar 26, 2023 •126 likes •238 views

Adverse event reporting in pigs Ken Steen Pedersen www.oevet.dk -VET A/S -Vet A/S was founded in 1996 and today consists of 15 people www.oevet.dk -Vet A/S Farms visited regulary Farms visited ocasionally www.oevet.dk Veterinarian

  1. Adverse event reporting in pigs Ken Steen Pedersen www.oevet.dk

  2. Ø-VET A/S Ø-Vet A/S was founded in 1996 and today consists of 15 people www.oevet.dk

  3. Ø-Vet A/S Farms visited regulary Farms visited ocasionally www.oevet.dk

  4. Veterinarian Ken Steen Pedersen Company: Ø-Vet A/S 2003: DVM, Royal Veterinary and Agricultural University 2003: Swine practitioner, Veterinary assistant 2006: Chief Veterinarian and shareholder, Ø-VET 2011: Diplomate by examination of ECPHM 2012: PhD 2012: Assistant Professor in Pig Diseases 2013: Chief scientist, Pig Research Centre 2015: CEO, Partner, Ø-VET A/S 2015: Affiliated Associated Professor in Pig diseases, University CPH www.oevet.dk

  5. The current situation Not many problems with adverse effects Generally content with current situation www.oevet.dk

  6. Examples of suspected adverse events Reported: Significant visible pathological reaction Significant visible pathophysiological reaction Significant lack of efficacy – specific disease Also important is link between use and event www.oevet.dk

  7. Examples of suspected adverse events Not Reported: Minor visible pathological reaction Minor visible pathophysiological reaction Minor lack of efficacy – specific disease or negative production results Less obvious link between use and event www.oevet.dk

  8. Increased information from vets to regulators on adverse effects More information: When to report events How to report events The level of need documentation needed The benefit for vets, industry and food safty www.oevet.dk

  9. Information regarding the safety and efficacy from regulators to vets Access to raw data from all countries in the EU Electronic system with some level of information to vets www.oevet.dk

  10. Organisation/expert group at EU level www.oevet.dk

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Adverse Event Reporting at ClinicalTrials.gov Deborah A. Zarin , M.D. Director,

Adverse Event Reporting at ClinicalTrials.gov Deborah A. Zarin , M.D. Director,

Adverse Event Reporting at ClinicalTrials.gov Deborah A. Zarin , M.D. Director, ClinicalTrials.gov National Library of Medicine/NIH November 2010 1 Adverse Event Reporting under FDAAA FDAAA Title VIII covers certain clinical trials of

424 views • 10 slides
Network analysis of possible anaphylaxis cases reported to the US Vaccine Adverse Event Reporting

Network analysis of possible anaphylaxis cases reported to the US Vaccine Adverse Event Reporting

Network analysis of possible anaphylaxis cases reported to the US Vaccine Adverse Event Reporting System after H1N1 influenza vaccine Taxiarchis Botsis 1,2 & Robert Ball 1 1 Center for Biologics Evaluation and Research (CBER), U.S. Food and

384 views • 11 slides
US Health Care Professional Perspectives on Adverse Drug Event Reporting in the Hospital Setting

US Health Care Professional Perspectives on Adverse Drug Event Reporting in the Hospital Setting

US Health Care Professional Perspectives on Adverse Drug Event Reporting in the Hospital Setting and the Opportunity for Information Technology Gustavo Grampp Amgen Inc. ! Stella Stergiopoulos, Tufts CSDD; Carrie A. Brown, Tufts University;

269 views • 14 slides
Client Alert FDA Issues Draft Guidance on Postmarketing Adverse Event Reporting Contact Attorneys

Client Alert FDA Issues Draft Guidance on Postmarketing Adverse Event Reporting Contact Attorneys

Client Alert FDA Issues Draft Guidance on Postmarketing Adverse Event Reporting Contact Attorneys Regarding for Nonprescription Human Drug Products Marketed Without an Ap- This Matter: proved Application Alan G. Minsk INtRoDuctIoN

371 views • 4 slides
Medical Devices: how to stay included Adverse event reporting and all it entails Sharon Bennett

Medical Devices: how to stay included Adverse event reporting and all it entails Sharon Bennett

Medical Devices: how to stay included Adverse event reporting and all it entails Sharon Bennett IRIS Coordinator Medical Devices Branch Therapeutic Goods Administration Learning outcomes It is envisaged at the end of this session you will be

547 views • 25 slides
http://finance.practicallaw.com/4-524-0432 14/02/2013 PLC - Material adverse change event

http://finance.practicallaw.com/4-524-0432 14/02/2013 PLC - Material adverse change event

PLC - Material adverse change event established and appropriation not i... Page 1 of 9 Material adverse change event established and appropriation not invalid but relief from forfeiture available (Privy Council) Resource type: Legal update: case

227 views • 9 slides
Biovigilance Component Hemovigilance Module Adverse Reaction and Denominator Reporting National

Biovigilance Component Hemovigilance Module Adverse Reaction and Denominator Reporting National

Biovigilance Component Hemovigilance Module Adverse Reaction and Denominator Reporting National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion 1 Objectives Review adverse reaction reporting

1.01k views • 39 slides
Biovigilance Component Hemovigilance Module Adverse Reaction and Denominator Reporting National

Biovigilance Component Hemovigilance Module Adverse Reaction and Denominator Reporting National

Biovigilance Component Hemovigilance Module Adverse Reaction and Denominator Reporting National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion 1 Objectives Review adverse reaction reporting

727 views • 36 slides
Healthcare Professionals W orking Group ( HCPW G) : Reporting of adverse drug reactions by w

Healthcare Professionals W orking Group ( HCPW G) : Reporting of adverse drug reactions by w

Healthcare Professionals W orking Group ( HCPW G) : Reporting of adverse drug reactions by w eb-based form s Sabine Brosch and Victoria Newbould An agency of the European Union Adverse Reaction reporting by healthcare professionals New

328 views • 28 slides
W orking Party w ith Patients' and Consum ers' Organisations ( PCW P) : Reporting of adverse drug

W orking Party w ith Patients' and Consum ers' Organisations ( PCW P) : Reporting of adverse drug

W orking Party w ith Patients' and Consum ers' Organisations ( PCW P) : Reporting of adverse drug reactions by patients and consum ers An agency of the European Union Adverse Reaction reporting by Patients and Consumers New

612 views • 26 slides
Knowledge about Adverse Drug Reaction and reporting among the

Knowledge about Adverse Drug Reaction and reporting among the

Knowledge about Adverse Drug Reaction and reporting among the healthcare professionals in Bhutan(O 24) Msc. Choki Dorji (Clinical Pharmacy) Chokidorji_bkk@outlook.com

541 views • 10 slides
Reference Chuang-Stein C, Beltangady M. (2011 ) Reporting cumulative proportion of

Reference Chuang-Stein C, Beltangady M. (2011 ) Reporting cumulative proportion of

Reporting Cumulative Proportion of Subjects with an Adverse Event Based on Data from Multiple Studies Christy Chuang-Stein Statistical Research and Consulting Center Pfizer Inc 18 April 2012 PSI Journal Club 1 delete these guides from slide

125 views • 10 slides
AE Toxicity Grading for Why do we care????? Transplant Patients Toxicity vs Adverse

AE Toxicity Grading for Why do we care????? Transplant Patients Toxicity vs Adverse

Objectives AE Toxicity Grading for Why do we care????? Transplant Patients Toxicity vs Adverse Event vs Serious Adverse Event Marcie Tomblyn, MD, MS Importance of accurate toxicity grading Associate Member Director, BMT Clinical

69 views • 5 slides
Reporting of Adverse Drug Reactions by Patients Croatian Experience Marina Dimov Di Giusti,

Reporting of Adverse Drug Reactions by Patients Croatian Experience Marina Dimov Di Giusti,

Reporting of Adverse Drug Reactions by Patients Croatian Experience Marina Dimov Di Giusti, MD, MSc. 06-07 May 2013, Dubrovnik, Croatia Reporting of ADRs Rare and unexpected ADRs mainly identified in post marketing phase Health

363 views • 34 slides
Overview of SG2 SG2 Terms of Reference Examine the requirements for the reporting of medical

Overview of SG2 SG2 Terms of Reference Examine the requirements for the reporting of medical

Overview of SG2 SG2 Terms of Reference Examine the requirements for the reporting of medical device adverse incidents involving medical devices, Recommend ways to harmonize: Reporting requirements of medical device adverse events

470 views • 14 slides
Reporting of Serious Adverse Events and Reactions RENAL TRANSPLANT SERVICES MEETING (RTSM)

Reporting of Serious Adverse Events and Reactions RENAL TRANSPLANT SERVICES MEETING (RTSM)

Reporting of Serious Adverse Events and Reactions RENAL TRANSPLANT SERVICES MEETING (RTSM) JANUARY 2013 Sue Falvey SAE - DEFINITION any undesired and unexpected occurrence associated with any stage of the chain from donation to

276 views • 11 slides
A Rare Presentation of Orbital Roof Blow-out Fracture with Intact Vision Article September 2019

A Rare Presentation of Orbital Roof Blow-out Fracture with Intact Vision Article September 2019

See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/336003566 A Rare Presentation of Orbital Roof Blow-out Fracture with Intact Vision Article September 2019 DOI: 10.3126/egn.v1i2.25732

368 views • 3 slides
and domestic demand Frdric Lanon UMR Artdev, CIRAD frederic.lancon@cirad.fr Domestic

and domestic demand Frdric Lanon UMR Artdev, CIRAD frederic.lancon@cirad.fr Domestic

FERDI-AFD workshop Agricultural value chain development and smallholder competitiveness Chanes de valeur agricoles et comptitivit de lagriculture familiale Thursday November 15, 2018, at AFD Headquarters in Paris Agricultural Value

398 views • 12 slides
iv ing I nno va tio n in Crisis Ma na g e me nt fo r E uro pe a n R e silie nc e Dr T o m De

iv ing I nno va tio n in Crisis Ma na g e me nt fo r E uro pe a n R e silie nc e Dr T o m De

T his pro je c t ha s re c e ive d funding fro m the E uro pe a n Unio n s Se ve nth F ra me wo rk Pro g ra mme fo r re se a rc h, te c hno lo g ic a l de ve lo pme nt a nd de mo nstra tio n unde r g ra nt a g re e me nt no 607798 iv ing

157 views • 13 slides
YOUR P ARTNER ON FLEXIBLE P ACKAGING CONVERTING SOLUTIONS CATALONIA - SPAIN NORTH AMERICA

YOUR P ARTNER ON FLEXIBLE P ACKAGING CONVERTING SOLUTIONS CATALONIA - SPAIN NORTH AMERICA

YOUR P ARTNER ON FLEXIBLE P ACKAGING CONVERTING SOLUTIONS CATALONIA - SPAIN NORTH AMERICA Headquarters Manufacturing sites BRAZIL ITALY Spare parts warehouses Service sites Showrooms Sales network 500 132 2% Million euros R + D

306 views • 29 slides
INVESTOR PRESENTATION September 2016 FORWARD-LOOKING STATEMENTS AND NON-GAAP MEASURES Some of

INVESTOR PRESENTATION September 2016 FORWARD-LOOKING STATEMENTS AND NON-GAAP MEASURES Some of

INVESTOR PRESENTATION September 2016 FORWARD-LOOKING STATEMENTS AND NON-GAAP MEASURES Some of the statements in this presentation constitute forward - looking statements about Sunoco LP (SUN, we, our, and us), and their

659 views • 28 slides
South Kensington Station Future Retail Strategy Interim Report Presentation to the

South Kensington Station Future Retail Strategy Interim Report Presentation to the

South Kensington Station Future Retail Strategy Interim Report Presentation to the Consultative Working Group, on behalf of Prepared by The Retail Group 6 July 2016 Content Project Objectives Study Area Map Footfall Study and

787 views • 21 slides
Summary of FY20/3 Online Results Presentation Q&A Session (May 13, 2020, Tokyo)

Summary of FY20/3 Online Results Presentation Q&A Session (May 13, 2020, Tokyo)

Nichirei Corporation Summary of FY20/3 Online Results Presentation Q&A Session (May 13, 2020, Tokyo) (Introduction) Hello. Im Nichirei President Kenya Okushi. Thank you for joining our results presentation today. Because of the emergency

70 views • 3 slides
Convenience Trends 2016 September 27, 2016 Chelsea Gross | chelsea.gross@retailnetgroup.com

Convenience Trends 2016 September 27, 2016 Chelsea Gross | chelsea.gross@retailnetgroup.com

CDA Convenience Trends 2016 September 27, 2016 Chelsea Gross | chelsea.gross@retailnetgroup.com Todays Session Convenience Learning from Intro Forecasts Summary Store Initiatives the Disruptors Real-time Retail Channel View

767 views • 33 slides

More recommend